Share of Cost, Study finds that belief that Tourette’s patients are aggressive to be a myth
Wednesday, Sep. 27th 2017 6:00 AM
It is commonly believed that people with Tourette’s syndrome tend to be aggressive. Now a new study, being presented at the ECNP Congress in Vienna, shows that people with Tourette’s are no more aggressive than anyone else.
Related posts:
- Share of Cost, According to Studies Done it Finds Dementia Care Costs Equal Costs of Cancer & Heart Disease Share of Cost, According to Studies Done it Finds Dementia Care Costs Equal Costs of Cancer & Heart Disease...
- Share of Cost, New survey finds strokes of unknown cause leave patients, caregivers in the dark Share of Cost, New survey finds strokes of unknown cause leave patients, caregivers in the dark...
- Share of Cost, Reaction to violent media depends on each individual’s brain circuitry Share of Cost, Reaction to violent media depends on each individual's brain circuitry...
- Study Helps Explain ‘Sundowning,’ An Anxiety Syndrome In Elderly Dementia Patients New research provides the best evidence to date that the late-day anxiety and agitation sometimes seen in older institutionalized adults, especially those with dementia, has a biological basis in the brain. Consider our share of cost dental plans to help you. Contact our office during regular business hours Monday – Friday 8am – 5pm PST […]...
- Unhealthy Behaviors More Prevalent In Survivors Of Multiple Cancers, Study Shows Unhealthy Behaviors More Prevalent In Survivors Of Multiple Cancers, Study Shows...
- Study Suggest That Upper Endoscopy Overused in Patients with Heartburn Study Suggest That Upper Endoscopy Overused in Patients with Heartburn...
- Share of Cost, Study Suggests Coronary Stents Not Harmful To Patients With History Of Metal Allergy Study is first to compare clinical outcomes after placing stents in those with and without a history of skin allergy to stent metal components. Cardiologists have long grappled with how to best manage patients with coronary artery disease who report skin hypersensitivity to nickel or other metal components found in stents — small tubes placed […]...
- Study Shows Promise For New Drug To Treat Fragile X Study Shows Promise For New Drug To Treat Fragile X...
- Share of Cost, According to a Study, Dogs Are Similar To Young Kids Share of Cost, According to a Study, Dogs Are Similar To Young Kids...
- Share of Cost, Diabetes patients cope better when they have a positive outlook and social support Share of Cost, Diabetes patients cope better when they have a positive outlook and social support...
- A Collaborative of Leading Health Systems Finds Wide Variations in Total Knee Replacement Delivery and Takes Steps to Improve Value Members of a consortium of leading US health care systems, known as the High Value Healthcare Collaborative, used administrative data to examine differences in their delivery of primary total knee replacement. The goal was to identify opportunities to improve health care value by increasing the quality and reducing the cost of that procedure. The study […]...
- Leading Researchers To Share New Treatments At Fragile X International Conference Accelerated research findings leading to potentially significant new treatments for fragile X syndrome (FXS) will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25…...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study New York Share of Cost, Zegerid OTC Provides Greater And Faster Acid Control Than Prevacid 24HR According To Head-To-Head Clinical Study: Merck Consumer Care has announced results of a head-to-head clinical study showing that ZEGERID OTC™ offers greater and faster acid control than Prevacid® 24HR. While acid control is an industry standard measure for acid-reducing […]...
- Study on How Glucocorticoid Hormones Shut off Key Immune System Genes Study on How Glucocorticoid Hormones Shut off Key Immune System Genes...
Posted on Wednesday, Sep. 27th 2017 6:00 AM | by Share of Cost | in Share of Cost | No Comments »